Ligand validation:7DQI

AX7: 1H-benzimidazol-2-amine

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7DQI_AX7_A_301	45%	52%	0.158	0.888	0.98	0.89	-	-	0	0	100%	1
5Z9B_AX7_A_304	87%	51%	0.084	0.955	1.03	0.86	1	-	0	0	100%	1
7DPS_AX7_A_301	37%	49%	0.197	0.894	1.07	0.92	1	-	1	0	100%	1
5PAR_AX7_C_506	85%	47%	0.096	0.961	1.31	0.77	1	-	0	0	100%	1
5Z9P_AX7_B_301	84%	52%	0.074	0.936	1	0.88	-	-	0	0	100%	1
3KQS_AX7_A_290	78%	4%	0.129	0.973	5.11	0.54	8	-	0	0	100%	1
6EQ5_AX7_A_201	62%	21%	0.141	0.932	2.05	1.28	3	1	0	0	100%	1
3GN1_AX7_D_270	51%	61%	0.139	0.894	1.04	0.48	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.